Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 5, 2003, Pages 930-934

  Bochner, Bruce S ^a   Hudson, Sherry A ^a   Xiao, Hui Qing ^a   Liu, Mark C ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Chemokines; I 309; IP 10; MDC; Pulmonary late phase response; Segmental allergen challenge; TARC

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I 309; INTERLEUKIN 18; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ADULT; ALLERGENICITY; ANTIBODY COMBINING SITE; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; BINDING SITE; CELL COUNT; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; INFLAMMATION; INTERMETHOD COMPARISON; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; STATISTICAL SIGNIFICANCE; TH2 CELL;

EID: 0242550716     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2003.08.012     Document Type: Article

References (31)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-62.
2. + T-cells, increased Th2-type cytokine messenger RNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-24.
3. Liu MC, Proud D, Lichtenstein LM, Hubbard WC, Bochner BS, Stealey BA, et al. Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol 2001;108:29-38.
4. Bochner BS. Road signs guiding leukocytes along the inflammation superhighway. J Allergy Clin Immunol 2000;106:817-28.
5. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:2005-7.
6. D'Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A, et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998;161:5111-5.
7. Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlazzi CT, Sinigaglia F, et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998;I61:547-51.
8. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-34.
9. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999;11:81-8.
10. Yamamoto J, Adachi Y, Onoue Y, Adachi YS, Okabe Y, Itazawa T, et al. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells. J Leukoc Biol 2000;68:568-74.
11. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881-5.
12. Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M, et al. Eosinophil chemotactic chemokines (Eotaxin, Eotaxin-2, RANTES, Monocyte Chemoattractant Protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999;163:6321-9.
13. Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, Bellettato C, et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001;107:1357-64.
14. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001;108:1331-9.
15. H2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000;165:2205-13.
16. Campbell JJ, Brightling CE, Symon FA, Qin S, Murphy KE, Hodge M, et al. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 2001;166:2842-8.
17. Kay AB. Allergy and allergic diseases. Part 1. N Engl J Med 2001;344:30-7.
18. Kay AB. Allergy and allergic diseases. Part 2. N Engl J Med 2001;344:109-13.
19. Huang SK, Xiao HQ, Kleine-Tebbe J, Pacrotti G, Marsh DG, Lichtenstein LM, et al. IL-13 expression at sites of allergen challenge in patients with asthma. J Immunol 1995;155:2688-94.
20. Lilly CM, Nakamura H, Belostotsky OI, Haley KJ, Garda-Zepeda EA, Luster AD, et al. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med 2001;163:1669-75.
21. Miyazaki E, Nureki S, Fukami T, Shigenaga T, Ando M, Ito K, et al. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am J Respir Crit Care Med 2002;165:1125-31.
22. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986;60:532-8.
23. Kelly CA, Fenwick JD, Corris PA, Fleetwood A, Hendrick DJ, Walters EH. Fluid dynamics during bronchoalveolar lavage. Am Rev Respir Dis 1988;138:81-4.
24. Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Li K, et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002;169:1037-49.
25. Murphy PM, Rothenberg ME. Chemokine receptors. In: Rothenberg ME, editor. Chemokines in allergic disease. New York: Marcel Dekker; 2000. p. 53-66.
26. Miotto D, Christodoulopoulos P, Olivenstein R, Taha R, Cameron L, Tsicopoulos A, et al. Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 2001;107:664-70.
27. Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, et al. The T cell-specific CXC chemokines IP-10. Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999;162:3549-58.
28. Bonecchi R, Sozzani S, Stine JT, Luini W, D'Amico G, Allavena P, et al. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 1998;92:2668-71.
29. Berin MC, Eckmann L, Broide DH, Kagnoff MF. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 2001;24:382-9.
30. Hasday JD, Meltzer SS, Moore WC, Wisniewski P, Hebel JR, Lanni C, et al. Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics. Am J Respir Crit Care Med 2000;161:1229-36.
31. Bochner BS, Bickel CA, Taylor ML, MacGlashan DW Jr, Gray PW, Raport CJ, et al. Macrophage derived chemokine (MDC) induces human eosinophil chemotaxis in a CCR3-and CCR4-independent manner. J Allergy Clin Immunol 1999;103:527-32.